This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2017 Apr 11;317(14):1482.

doi: 10.1001/jama.2017.2823.

No authors listed

Published Erratum

No authors listed. JAMA. 2017.

. 2017 Apr 11;317(14):1482.

doi: 10.1001/jama.2017.2823.

No abstract available

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.
Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2016 Dec 13;316(22):2357-2358. doi: 10.1001/jama.2016.16437. JAMA. 2016. PMID: 27775756 No abstract available.